The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression
The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression
复制标题
DOI:
10.1016/j.ejca.2016.09.012
复制
发表时间:
2016-11-01
影响因子:
8.4
通讯作者:
Fodde, Riccardo
中科院分区:
文献类型:
--
作者:
Atlasi, Yaser;Noori, Rubina;Fodde, Riccardo
Introduction: S100a4 is a calcium-binding protein belonging to the family of S100-proteins, highly expressed in different stromal cell types. S100A4 has been reported as a prognostic marker in colorectal cancer in association with tumour progression and metastasis.Methods: In this study, we analysed the in vivo role of S100a4 in intestinal tumour initiation and progression using different transgenic and knockout mouse models.Results: We found that genetic ablation or overexpression of S100a4 in both Apc- and Smad4-mutant mice do not affect tumour initiation in the intestinal tract. In contrast, S100a4 epithelial overexpression in Apc(1638N/+)/KRAS(V12G) mice increases the dissemination of intestinal tumour cells to the liver, in agreement with its role in tumour metastasis. Moreover, we report a novel role for S100a4 in desmoid formation where S100a4 deficiency results in a significant reduction of the tumour burden characteristic of the Apc(1638N) model. In agreement with these results, S100a4 appears to be co-expressed together with mesenchymal stem cell (MSC) markers in desmoid tumours from Apc(1638N/+) mice, as well as from sporadic and hereditary human desmoids.Conclusion: Our data provide the first report on the in vivo role of S100a4 in intestinal tumourigenesis and describe a new role for S100a4 in the aetiology of desmoids formation. (C) 2016 Elsevier Ltd. All rights reserved.